Search Results - "Eccles, B K"

Understanding of BRCA VUS genetic results by breast cancer specialists by Eccles, B K, Copson, E, Maishman, T, Abraham, J E, Eccles, D M

“…Mainstreaming genetic medicine, increased media coverage and clinical trials for BRCA mutation carriers are leading oncologists into more patient discussions…”
Get full text

Obesity and the outcome of young breast cancer patients in the UK: the POSH study by Copson, E.R., Cutress, R.I., Maishman, T., Eccles, B.K., Gerty, S., Stanton, L., Altman, D.G., Durcan, L., Wong, C., Simmonds, P.D., Jones, L., Eccles, D.M.

“…Obese breast cancer patients have a poorer prognosis than non-obese patients. We examined data from a large prospective cohort study to explore the…”
Get full text

Experience of first- and subsequent-line systemic therapy in the treatment of non-small cell lung cancer by Eccles, B. K., Geldart, T. R., Laurence, V. M., Bradley, K. L., Lwin, M. T.

“…Introduction: The treatment of advanced non-small cell cancer (NSCLC) has changed with multiple new treatment algorithms proposed based on histological and…”
Get full text

Prospective DPYD testing in colorectal cancer patients in a realworld UK population by Eccles, B K, Harle, A S, Pullinger, S, Holling, C, Ingram, A, Stark, S, Bunce, M, Melville, G, Gibbins, J, Calcutt, N, Hickish, T, Flubacher, M, Marinaki, T

Get full text

Family history and outcome of young patients with breast cancer in the UK (POSH study) by Eccles, B. K., Copson, E. R., Cutress, R. I., Maishman, T., Altman, D. G., Simmonds, P., Gerty, S. M., Durcan, L., Stanton, L., Eccles, D. M.

“…Background Young patients presenting to surgical clinics with breast cancer are usually aware of their family history and frequently believe that a positive…”
Get full text

560PProspective DPYD testing in colorectal cancer patients in a realworld UK population by Eccles, B K, Harle, A S, Pullinger, S, Holling, C, Ingram, A, Stark, S, Bunce, M, Melville, G, Gibbins, J, Calcutt, N, Hickish, T, Flubacher, M, Marinaki, T

Get full text

600PTrifluridine/tipiracil in metastatic colorectal cancer: An updated multicentre real-world analysis on efficacy, safety and predictive factors by Stavraka, C, Pouptsis, A, Synowiec, A, Aggelis, V, Satterthwaite, L, Khan, S, Chauhan, M, Holden, C E, Young, S, Karampera, C, Martinou, M, Mills-Baldock, T, Baxter, M, Eccles, B K, Iveson, T J, Shiu, K-K, Hill, M E, Abdel-Raouf, S, Thomas, A, Ross, P J

“…Abstract Background The orally administered combination trifluridine and tipiracil hydrochloride (TAS-102) has been approved as third line treatment in…”
Get full text

Abstract P2-12-01: BRCA1 and BRCA2 in multifocal cancers: Results from the POSH study by Eccles, BK, Maishman, T, Copson, E, Stanton, L, Eccles, DM

“…Abstract Background: Multifocal (MF) breast cancers are more common in pre and perimenopausal women and in estrogen receptor (ER) positive disease. Young onset…”
Get full text

Obesity and the outcome of young breast cancer patients in the UK: the POSH study by Copson, E R, Cutress, R I, Maishman, T, Eccles, B K, Gerty, S, Stanton, L, Altman, D G, Durcan, L, Wong, C, Simmonds, P D, Jones, L, Eccles, D M

“…Obese breast cancer patients have a poorer prognosis than non-obese patients. We examined data from a large prospective cohort study to explore the…”
Get full text

Abstract P6-06-06: Family history and young breast cancer patients in the UK: The POSH study by Copson, ER, Cutress, RI, Eccles, BK, Maishman, T, Stanton, L, Eccles, DM

“…Abstract Background Approximately 4% of breast cancer cases occur in women under 40 years. Young age at diagnosis is associated with inferior survival compared…”
Get full text